1 result for "The Methodist Hospital"
Add this URL to any RSS reader. Updated daily.
PSMA-Targeted Cancer Immunotherapy Patent Granted to Methodist Hospital
The USPTO granted patent US12605446B2 to The Methodist Hospital covering engineered cells with chimeric antigen receptors (CARs) targeting PSMA for prostate cancer treatment. The patent, filed August 20, 2021, contains 15 claims and names Bin He as inventor. This grant confers exclusive IP rights for PSMA-targeted CAR-T immunotherapies in the United States.
Routine
Rule
Intellectual Property
Get alerts for "The Methodist Hospital"
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Browse Categories
Agriculture & Food Safety
73
AI Regulation
3
Banking & Finance
406
Consumer Protection
89
Courts & Legal
411
Data Privacy & Cybersecurity
90
Defense & National Security
53
Education
55
Energy
100
Environment
151
Gaming
2
Government & Legislation
430
Healthcare
15
Healthcare & Life Sciences
375
Immigration
10
Insurance
76
Labor & Employment
132
Pharma & Drug Safety
21
Professional Licensing
8
Real Estate & Housing
78
Securities & Markets
154
Tax
78
Telecom & Technology
47
Trade & Sanctions
141
Transportation
91
Get alerts for "The Methodist Hospital"
We'll email you when new changes match "The Methodist Hospital".
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.
You're subscribed!